MicroBase Technology Corp. (3184.TWO) Stock
MicroBase Technology Corp., founded in 1997 and headquartered in Taoyuan City, Taiwan, specializes in providing critical drug administration solutions to patients and medical professionals throughout Taiwan. A key area of their expertise involves pioneering the development of non-silicon-based Micro-Electro-Mechanical Systems (MEMS) by leveraging LIGA technology.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About MicroBase Technology Corp.
MicroBase Technology Corp., founded in 1997 and headquartered in Taoyuan City, Taiwan, specializes in providing critical drug administration solutions to patients and medical professionals throughout Taiwan. A key area of their expertise involves pioneering the development of non-silicon-based Micro-Electro-Mechanical Systems (MEMS) by leveraging LIGA technology. This sophisticated method facilitates the engineering and production of extremely small devices and micron-sized components. Their product offerings include "Pocket Air," an innovative inhalation device designed to assist individuals with respiratory conditions, and "PharMatrix," a line of micro-needle products tailored for convenient at-home application by women.
MicroBase Technology Corp. is led by CEO Tian Lai Liu, employs 120 people, headquartered in Taoyuan City, TW, publicly traded since 2013.
over the past 52 weeks the stock has ranged between $8.40 and $35.90, and currently trades 63.2% below its 52-week high.
Official website: microbasetech.com